The genetic variations of RAD51 and its paralogs may contribute to the development of cancer, as has been shown in the case of breast, ovarian, endometrial, colorectal, and head and neck cancer and acute leukemia [8–11]. This evidence concerns the gene RAD51 and head and neck cancer.